Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma
Daniel Shu(University of Maryland, Baltimore), Mark Yarchoan(Sidney Kimmel Comprehensive Cancer Center)
Cited by 84
Related Papers
Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity
|Clinical Cancer Research|2017|181